Innovating Novel Therapeutics and Bettering Lives

OUR MISSION

mabwell home 01 hand

Unconventional Antibody Therapeutics

We are striving to improve the lives of people with rare, debilitating diseases by leveraging the promise of science into novel antibody therapeutics.

Our Company

PIPELINE

The Science Behind Our Approach

Following rigorous research and development guidelines, we are advancing antibody drugs that address unmet medical needs. We pinpoint targets, uncover lead molecules, and leverage antibody engineering to boost the chance of favorable outcomes.

PIPELINE
mabwell home 02 genes

What’s Happening
at Mabwell Therapeutics


PRESS RELEASES

January 18, 2022

Mabwell is Officially Listed on the Shanghai Stock Exchange STAR Market

Read more

October 19, 2021

China’s First Anti-Nectin-4 ADC Drug Receives IND Approval

Read more

Want to be part of the journey?